Figure 6 — ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network

Research Paper|Volume 15, Issue 24|pp. 14996–15024

ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network

Back to articleFigure 6(6 of 12)

100%

Figure 6.Relationship between ATRX and target genes in GSE1. The relationship between ATRX and the target genes of AR (A), GATA2 (B) and GLI3 (C). (D) GSEA analysis of AR’s target genes.